BUTITTA CYNTHIA M

CIK 00012220826 companiesLONDON

SEC Profile

Transactions

Companies

Filings

CIK

0001222082

Recent Transactions

50 trades

Exercise/Conversion
UroGen Pharma Ltd.$URGN
ordinary shares
2025-11-26+2,000→ 2,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Unit
2025-11-26−2,000→ 6,000 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2025-08-26+10,000→ 10,000 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Unit
2025-08-26+8,000→ 8,000 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2025-06-12+44,000→ 44,000 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2025-06-11+24,150→ 24,150 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2024-08-06+10,000→ 10,000 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2024-06-20+44,000→ 44,000 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2024-06-14+23,000→ 23,000 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2023-09-07+10,000→ 10,000 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2023-06-27+44,000→ 44,000 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2023-06-16+21,520→ 21,520 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2022-06-17+21,520→ 21,520 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2022-06-16+21,520→ 21,520 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2022-06-09+19,872→ 19,872 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-06-08+10,000→ 10,000 total
Award
Century Therapeutics, Inc.$IPSC
Option (right to buy)
2021-06-17+19,872→ 19,872 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2021-06-09+21,520→ 21,520 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2021-06-07+10,000→ 10,000 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2020-11-18+21,520→ 21,520 total
Exercise/Conversion
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2020-09-16−83,876→ 0 total
Exercise/Conversion
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2020-09-16$4.41/sh+83,876→ 83,876 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2020-08-12+83,876→ 83,876 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2020-06-08+10,000→ 10,000 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (Right to Buy)
2019-06-03+10,000→ 10,000 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$178.65/sh−44,110→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−36,284→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Common Stock
2017-10-03−93,667→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−90,600→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−28,034→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$163.00/sh−121,477→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−37,181→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$116.13/sh−28,919→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−23,437→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$128.04/sh−51,563→ 0 total
Award
Kite Pharma, Inc.
Common Stock
2017-09-25+8,000→ 125,795 total
Sale
Kite Pharma, Inc.
Common Stock
2017-09-25$179.66/sh−4,228→ 121,567 total
Gift
Kite Pharma, Inc.
Common Stock
2017-09-21−27,900→ 93,667 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-08-10$1.35/sh+15,000→ 132,795 total
Sale
Kite Pharma, Inc.
Common Stock
2017-08-10$120.52/sh−9,200→ 123,595 total
Sale
Kite Pharma, Inc.
Common Stock
2017-08-10$121.03/sh−5,800→ 117,795 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-08-10−15,000→ 80,394 total
Sale
Kite Pharma, Inc.
Common Stock
2017-07-10$105.50/sh−5,000→ 117,795 total
Sale
Kite Pharma, Inc.
Common Stock
2017-07-10$102.81/sh−1,100→ 122,795 total
Sale
Kite Pharma, Inc.
Common Stock
2017-07-10$102.19/sh−5,553→ 123,895 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-07-10$1.35/sh+15,000→ 132,795 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-07-10−15,000→ 95,394 total
Sale
Kite Pharma, Inc.
Common Stock
2017-07-10$101.06/sh−3,347→ 129,448 total
Sale
Kite Pharma, Inc.
Common Stock
2017-06-23$101.19/sh−2,050→ 112,795 total
Sale
Kite Pharma, Inc.
Common Stock
2017-06-23$100.54/sh−2,950→ 119,845 total

Companies

Recent Filings

Address

C/O AUTOLUS THERAPEUTICS PLC THE MEDIAWORKS, 191 WOOD LN, WHITE CITY

LONDON, W12 7FP

View on SEC.gov